Live News EQUITY FLASH L impact Nov 11, 2026, 01:00 PM UTC Amgen reports positive Phase 3 results for dazodalibep Amgen announced positive Phase 3 results for dazodalibep in Sjögren's disease. AMGN SquawkNews Desk